|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rolston KV: Infections in cancer patients
with solid tumors: A review. Infect Dis Ther. 6:69–83. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Honda Y: Lung cancer and respiratory
infections. Gan To Kagaku Ryoho. 47:750–753. 2020.(In Japanese).
PubMed/NCBI
|
|
4
|
Patel B and Priefer R: Impact of chronic
obstructive pulmonary disease, lung infection, and/or inhaled
corticosteroids use on potential risk of lung cancer. Life Sci.
294:1203742022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alexander M, Kim SY and Cheng H: Update
2020: Management of non-small cell lung cancer. Lung. 198:897–907.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vento S, Cainelli F and Temesgen Z: Lung
infections after cancer chemotherapy. Lancet Oncol. 9:982–992.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guckenberger M, Belka C, Bezjak A, Bradley
J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje
M, Gore E, et al: Practice recommendations for lung cancer
radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus
statement. Radiother Oncol. 146:223–229. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller JM, Binnicker MJ, Campbell S,
Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl
SC, Patel R, et al: A guide to utilization of the microbiology
laboratory for diagnosis of infectious diseases: 2018 update by the
Infectious Diseases Society of America and the American Society for
Microbiology. Clin Infect Dis. 67:e1–e94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: Introduction to the 2015 World Health
Organization classification of tumors of the lung, pleura, thymus,
and heart. J Thorac Oncol. 10:1240–1242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reinmuth N and Hoffmann H: Small Cell Lung
Cancer. TumorDiagnostik & Therapie. 43:307–320. 2022.(In
German).
|
|
12
|
Zhong J, Bai H, Wang Z, Duan J, Zhuang W,
Wang D, Wan R, Xu J, Fei K, Ma Z, et al: Treatment of advanced
non-small cell lung cancer with driver mutations: Current
applications and future directions. Front Med. 17:18–42. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iijima Y, Bandow K, Sano M, Hino S, Kaneko
T, Horie N and Sakagami H: In vitro assessment of antitumor
potential and combination effect of classical and
molecular-targeted anticancer drugs. Anticancer Res. 39:6673–6684.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Piperdi B, Merla A and Perez-Soler R:
Targeting angiogenesis in squamous non-small cell lung cancer.
Drugs. 74:403–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamba T and McDonald D: Mechanisms of
adverse effects of anti-VEGF therapy for cancer. Br J Cancer.
96:1788–1795. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uzel EK, Figen M and Uzel Ö: Radiotherapy
in lung cancer: Current and future role. Sisli Etfal Hastan Tip
Bul. 53:353–360. 2019.PubMed/NCBI
|
|
18
|
Howlader N, Noone A, Krapcho Me, Miller D,
Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al:
SEER cancer statistics review, 1975–2016. National Cancer
Institute; Bethesda, MD: 2019, https://seer.cancer.gov/csr/1975_2016/September
18–2023
|
|
19
|
Chen W, Zhong S, Shan B, Zhou S, Wu X,
Yang H and Ye S: Serum D-dimer, albumin and systemic inflammatory
response markers in ovarian clear cell carcinoma and their
prognostic implications. J Ovarian Res. 13:892020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dunn GP, Old LJ and Schreiber RD: The
immunobiology of cancer immunosurveillance and immunoediting.
Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schiavoni G, Sistigu A, Valentini M,
Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT,
Belardelli F, et al: Cyclophosphamide synergizes with type I
interferons through systemic dendritic cell reactivation and
induction of immunogenic tumor apoptosis. Cancer Res. 71:768–778.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kadakia KC, Symanowski JT, Aktas A,
Szafranski ML, Salo JC, Meadors PL and Walsh D: Malnutrition risk
at solid tumor diagnosis: The malnutrition screening tool in a
large US cancer institute. Support Care Cancer. 30:2237–2244. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mozaffari F, Lindemalm C, Choudhury A,
Granstam-Björneklett H, Helander I, Lekander M, Mikaelsson E,
Nilsson B, Ojutkangas ML, Osterborg A, et al: NK-cell and T-cell
functions in patients with breast cancer: Effects of surgery and
adjuvant chemo-and radiotherapy. Br J Cancer. 97:105–111. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun XY, Lin Y, Guo W and Yin XM:
Prognostic value of the geriatric nutritional risk index in
patients with non-small cell lung cancer: A meta-analysis. Nutr
Cancer. 74:3623–3633. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Worku M, Belay G and Tigabu A: Bacterial
profile and antimicrobial susceptibility patterns in cancer
patients. PLoS One. 17:e02669192022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mei T, Yang X, Yu Y, Tian X, Deng Q, Xu Y,
Zhou L, Zhou X, Liu Y, Zou B, et al: Secondary infections after
diagnosis of Severe Radiation Pneumonitis (SRP) among patients with
non-small cell lung cancer: Pathogen distributions, choice of
empirical antibiotics, and the value of empirical antifungal
treatment. Int J Radiat Oncol Biol Phys. 112:179–187. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Freire MP, de Oliveira Garcia D, Garcia
CP, Campagnari Bueno MF, Camargo CH, Kono Magri ASG, Francisco GR,
Reghini R, Vieira MF, Ibrahim KY, et al: Bloodstream infection
caused by extensively drug-resistant Acinetobacter baumannii in
cancer patients: High mortality associated with delayed treatment
rather than with the degree of neutropenia. Clin Microbiol Infect.
22:352–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu Z and Zou X: Analysis of factors for
susceptibility to a pulmonary fungal infection in elderly patients
with lung cancer and the drug resistance of those fungi. J Pathog
Biol. 3:633–636. 2018.(In Chinese).
|
|
29
|
Wilson O and Flahault A: China's U-turn in
its COVID-19 policy. Anaesth Crit Care Pain Med. 42:1011972023.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du Z, Wang Y, Bai Y, Wang L, Cowling BJ
and Meyers LA: Estimate of COVID-19 Deaths, China, December
2022-February 2023. Emerg Infect Dis. 29:2121–2124. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiao D, Wang Z, Lu Y, Wen X, Li H and Zhao
H: A retrospective study of risk and prognostic factors in relation
to lower respiratory tract infection in elderly lung cancer
patients. Am J Cancer Res. 5:423–432. 2015.PubMed/NCBI
|
|
32
|
Yu K, Sang QA, Lung PY, Tan W, Lively T,
Sheffield C, Bou-Dargham MJ, Liu JS and Zhang J: Personalized
chemotherapy selection for breast cancer using gene expression
profiles. Sci Rep. 7:432942017. View Article : Google Scholar : PubMed/NCBI
|
